Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-071689
Filing Date
2022-06-16
Accepted
2022-06-16 09:24:58
Documents
1
Period of Report
2022-06-14

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2218610-4_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2218610-4_4seq1.xml 4 4049
  Complete submission text file 0001104659-22-071689.txt   5719
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Issuer) CIK: 0001211583 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O IMMUNOMEDICS, INC. 300 THE AMERICAN ROAD MORRIS PLAINS NJ 07950
Business Address
Islam Khalid (Reporting) CIK: 0001701858 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32295 | Film No.: 221019455